← Open Payments lookup

LARRY KRAMER: Open Payments

NPI 1134118664 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$400 in 23 payments from 9 companies in 2025. Trend: 2023 $323 · 2024 $426 · 2025 $400

Food & beverage: $400
CompanyPaymentsAmount
ABBVIE INC.4$74
AstraZeneca Pharmaceuticals LP4$71
Novo Nordisk Inc3$49
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$40
Bayer Healthcare Pharmaceuticals Inc.2$37
Phathom Pharmaceuticals, Inc.3$37
Abbott Laboratories2$35
Lilly USA, LLC2$35
PFIZER INC.1$22

Products named: BREZTRI, XIFAXAN, Kerendia, VOQUEZNA, FREESTYLE LIBRE 3, VRAYLAR, MOUNJARO, Ozempic.

Industry payments across MD — which companies pay providers there.